We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index. Researche.....
Read more

We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s estimated up to 125 million people will have the con.....
Read more

Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging.....
Read more

Less than two years after a breast cancer diagnosis, Professor Gemma Figtree has completed the prestigious Boston Marathon while raising significant funds for cancer research. Gemma crossed the finish line in a sub four hour time as part of the talented team running for the internationally renowned Dana Farber Cancer Institute. Gemma ran her first marathon just after completing six months of chemot.....
Read more

With an increasing focus on our research activity, the Royal North Shore Hospital Scientific Staff Council is keen to celebrate the efforts of some of our emerging leaders. It has presented four awards recognising an outstanding commitment to research excellence. Kolling Institute musculoskeletal researchers Dylan Ashton and Dr Carina Blaker were joint winners of the best publication award for thei.....
Read more

One of our impressive researchers has taken out a prestigious national award to broaden treatment options for diabetes. Despite tough competition, Cameron Evans from the Cardiovascular Discovery Group has been awarded the 2024 Australian Centre for Accelerating Diabetes Innovation (ACADI) PhD grant. The funding means Cameron will be able to progress his research investigating the use of a new medic.....
Read more

At the Kolling Institute, we are tremendously fortunate to work with so many skilled and dedicated researchers. Our Kolling video gives you an insight into some of our latest research and our inspirational teams. Click here to view:
Read more

For many years we’ve understood that heart disease is linked to unhealthy habits and underlying health issues, but our researchers at the Kolling Institute are pioneering a new approach to identify and treat those with the disease without the traditional risk factors. In Australia, a heart attack occurs every nine minutes, often with a tragic outcome or lifelong consequences. Many of these attacks .....
Read more

We would like to congratulate Kolling Institute researcher Amanda Purcell who has received a Juvenile Diabetes Research Foundation scholarship. Amanda is part of our Renal Research Laboratory, working to improve treatment for those with diabetes and kidney disease. She has been awarded a top-up scholarship aimed at supporting PhD students pursuing type 1 diabetes research in line with the foundatio.....
Read more

With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease. Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated close to three million Australians will have the disease by 2025. It of.....
Read more